Vault-13

Boxer Capital, LLC

San Diego, CA · CIK 1465837 · 13F filing filed 2024-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.9bn reported value -6.2% vs Q1 2024
61positions
54.3%in top 10
4 new 4 added 2 reduced 2 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 4,279,464 $166.1m8.75% 8.75% UnchangedShares held: Q3 2023 4.7m, Q4 2023 4.3m, Q1 2024 4.3m, Q2 2024 4.3m
2 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 3,421,541 $128.9m6.79% 6.79% UnchangedShares held: Q3 2023 3.4m, Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m
3 CYTOKINETICS INC COM NEW CYTK CYTK 2,100,000 $113.8m5.99% 5.99% UnchangedShares held: Q3 2023 2.1m, Q4 2023 2.1m, Q1 2024 2.1m, Q2 2024 2.1m
4 MERUS N V COM MRUS MRUS 1,900,000 $112.4m5.92% 5.92% UnchangedShares held: Q3 2023 1.9m, Q4 2023 1.9m, Q1 2024 1.9m, Q2 2024 1.9m
5 TYRA BIOSCIENCES INC COM TYRA TYRA 6,448,359 $103.1m5.43% 5.43% UnchangedShares held: Q3 2023 6.4m, Q4 2023 6.4m, Q1 2024 6.4m, Q2 2024 6.4m
6 SAREPTA THERAPEUTICS INC COM SRPT SRPT 650,000 $102.7m5.41% 5.41% UnchangedShares held: Q3 2023 600.0k, Q4 2023 650.0k, Q1 2024 650.0k, Q2 2024 650.0k
7 NUVALENT INC COM COM 1,120,192 $85.0m4.48% 4.48% UnchangedShares held: Q3 2023 1.2m, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.1m
8 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,202,812 $77.3m4.07% 4.07% UnchangedShares held: Q3 2023 2.2m, Q4 2023 2.2m, Q1 2024 2.2m, Q2 2024 2.2m
9 BEIGENE LTD SPONSORED ADR ONC ONC 500,000 $71.3m3.76% 3.76% UnchangedShares held: Q3 2023 500.0k, Q4 2023 500.0k, Q1 2024 500.0k, Q2 2024 500.0k
10 AVIDITY BIOSCIENCES INC COM RNA RNA 1,727,388 $70.6m3.72% 3.72% UnchangedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.7m, Q2 2024 1.7m
11 TANGO THERAPEUTICS INC COM TNGX TNGX 8,198,642 $70.3m3.70% 3.70% UnchangedShares held: Q3 2023 7.1m, Q4 2023 8.2m, Q1 2024 8.2m, Q2 2024 8.2m
12 APELLIS PHARMACEUTICALS INC COM APLS APLS 1,726,000 $66.2m3.49% 3.49% UnchangedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.7m
13 ITEOS THERAPEUTICS INC COM ITOS ITOS 2,946,915 $43.7m2.30% 2.30% AddedShares held: Q3 2023 1.8m, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 2.9m +1.1m +1,142,857 63.4%
14 ARGENX SE SPONSORED ADR ARGX ARGX 100,000 $43.0m2.26% 2.26% UnchangedShares held: Q3 2023 85.0k, Q4 2023 160.0k, Q1 2024 100.0k, Q2 2024 100.0k
15 AKERO THERAPEUTICS INC COM AKRO AKRO 1,676,733 $39.3m2.07% 2.07% UnchangedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.7m
16 NKARTA INC COM NKTX NKTX 5,607,350 $33.1m1.75% 1.75% UnchangedShares held: Q3 2023 0, Q4 2023 1.4m, Q1 2024 5.6m, Q2 2024 5.6m
17 ANAPTYSBIO INC COM ANAB ANAB 1,300,000 $32.6m1.72% 1.72% UnchangedShares held: Q3 2023 1.3m, Q4 2023 1.3m, Q1 2024 1.3m, Q2 2024 1.3m
18 AXSOME THERAPEUTICS INC COM AXSM AXSM 400,000 $32.2m1.70% 1.70% UnchangedShares held: Q3 2023 400.0k, Q4 2023 400.0k, Q1 2024 400.0k, Q2 2024 400.0k
19 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,466,051 $31.6m1.66% 1.66% UnchangedShares held: Q3 2023 1.5m, Q4 2023 1.5m, Q1 2024 1.5m, Q2 2024 1.5m
20 FATE THERAPEUTICS INC COM FATE FATE 8,215,910 $26.9m1.42% 1.42% UnchangedShares held: Q3 2023 500.0k, Q4 2023 500.0k, Q1 2024 8.2m, Q2 2024 8.2m
21 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 600,000 $26.6m1.40% 1.40% UnchangedShares held: Q3 2023 600.0k, Q4 2023 600.0k, Q1 2024 600.0k, Q2 2024 600.0k
22 THIRD HARMONIC BIO INC COM COM 2,000,000 $26.0m1.37% 1.37% UnchangedShares held: Q3 2023 520.4k, Q4 2023 750.0k, Q1 2024 2.0m, Q2 2024 2.0m
23 GERON CORP COM GERN GERN 6,000,000 $25.4m1.34% 1.34% UnchangedShares held: Q3 2023 3.0m, Q4 2023 3.0m, Q1 2024 6.0m, Q2 2024 6.0m
24 ARCUS BIOSCIENCES INC COM RCUS RCUS 1,602,200 $24.4m1.29% 1.29% UnchangedShares held: Q3 2023 1.6m, Q4 2023 1.6m, Q1 2024 1.6m, Q2 2024 1.6m
25 XENON PHARMACEUTICALS INC COM XENE XENE 600,000 $23.4m1.23% 1.23% UnchangedShares held: Q3 2023 600.0k, Q4 2023 600.0k, Q1 2024 600.0k, Q2 2024 600.0k
26 IMMUNOVANT INC COM IMVT IMVT 825,000 $21.8m1.15% 1.15% UnchangedShares held: Q3 2023 750.0k, Q4 2023 1.0m, Q1 2024 825.0k, Q2 2024 825.0k
27 KURA ONCOLOGY INC COM KURA KURA 1,000,000 $20.6m1.08% 1.08% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.0m, Q2 2024 1.0m
28 KALVISTA PHARMACEUTICALS INC COM KALV KALV 1,590,000 $18.7m0.99% 0.99% UnchangedShares held: Q3 2023 1.6m, Q4 2023 1.6m, Q1 2024 1.6m, Q2 2024 1.6m
29 CLIMB BIO INC COM CLYM CLYM 2,603,190 $18.5m0.97% 0.97% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.6m
30 DAY ONE BIOPHARMACEUTICALS I COM COM 1,189,943 $16.4m0.86% 0.86% UnchangedShares held: Q3 2023 1.2m, Q4 2023 1.2m, Q1 2024 1.2m, Q2 2024 1.2m
31 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 696,480 $16.4m0.86% 0.86% AddedShares held: Q3 2023 0, Q4 2023 250.0k, Q1 2024 250.0k, Q2 2024 696.5k +446.5k +446,480 178.6%
32 ARVINAS INC COM ARVN ARVN 608,614 $16.2m0.85% 0.85% UnchangedShares held: Q3 2023 0, Q4 2023 608.6k, Q1 2024 608.6k, Q2 2024 608.6k
33 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 400,000 $15.7m0.83% 0.83% UnchangedShares held: Q3 2023 0, Q4 2023 400.0k, Q1 2024 400.0k, Q2 2024 400.0k
34 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 671,358 $15.7m0.83% 0.83% UnchangedShares held: Q3 2023 646.1k, Q4 2023 646.1k, Q1 2024 671.4k, Q2 2024 671.4k
35 PROTHENA CORP PLC SHS PRTA PRTA 690,000 $14.2m0.75% 0.75% UnchangedShares held: Q3 2023 625.0k, Q4 2023 665.0k, Q1 2024 690.0k, Q2 2024 690.0k
36 REPLIMUNE GROUP INC COM REPL REPL 1,536,341 $13.8m0.73% 0.73% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.5m
37 POSEIDA THERAPEUTICS INC COM PSTX PSTX 4,475,000 $13.1m0.69% 0.69% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 4.5m, Q2 2024 4.5m
38 CENTURY THERAPEUTICS INC COM IPSC IPSC 4,901,603 $12.5m0.66% 0.66% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.8m, Q2 2024 4.9m +3.2m +3,151,603 180.1%
39 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,732,571 $12.2m0.65% 0.65% UnchangedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.7m
40 RELAY THERAPEUTICS INC COM RLAY RLAY 1,819,132 $11.9m0.62% 0.62% UnchangedShares held: Q3 2023 1.8m, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 1.8m
41 CULLINAN THERAPEUTICS INC COM CGEM CGEM 657,895 $11.5m0.60% 0.60% NewShares held: Q3 2023 1.1m, Q4 2023 0, Q1 2024 0, Q2 2024 657.9k
42 PRELUDE THERAPEUTICS INC COM PRLD PRLD 2,568,287 $9.8m0.52% 0.52% UnchangedShares held: Q3 2023 2.5m, Q4 2023 2.6m, Q1 2024 2.6m, Q2 2024 2.6m
43 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 3,850,000 $9.0m0.47% 0.47% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.9m, Q2 2024 3.9m
44 SANA BIOTECHNOLOGY INC COM SANA SANA 1,545,000 $8.4m0.44% 0.44% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.5m, Q2 2024 1.5m
45 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 350,000 $7.9m0.42% 0.42% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 350.0k, Q2 2024 350.0k
46 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 650,000 $7.0m0.37% 0.37% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 650.0k
47 ENGENE HOLDINGS INC COM COM 727,900 $6.9m0.36% 0.36% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 727.9k, Q2 2024 727.9k
48 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 750,000 $6.0m0.32% 0.32% UnchangedShares held: Q3 2023 3.7m, Q4 2023 1.4m, Q1 2024 750.0k, Q2 2024 750.0k
49 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 1,500,000 $2.9m0.15% 0.15% UnchangedShares held: Q3 2023 2.1m, Q4 2023 0, Q1 2024 1.5m, Q2 2024 1.5m
50 BOUNDLESS BIO INC COM BOLD BOLD 711,329 $2.8m0.14% 0.14% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 711.3k, Q2 2024 711.3k
51 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 506,000 $2.4m0.12% 0.12% UnchangedShares held: Q3 2023 506.0k, Q4 2023 506.0k, Q1 2024 506.0k, Q2 2024 506.0k
52 ABSCI CORPORATION COM ABSI ABSI 700,000 $2.2m0.11% 0.11% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 700.0k, Q2 2024 700.0k
53 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 238,193 $1.9m0.10% 0.10% UnchangedShares held: Q3 2023 238.2k, Q4 2023 238.2k, Q1 2024 238.2k, Q2 2024 238.2k
54 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 450,000 $1.8m0.10% 0.10% UnchangedShares held: Q3 2023 450.0k, Q4 2023 450.0k, Q1 2024 450.0k, Q2 2024 450.0k
55 PROTARA THERAPEUTICS INC COM STK TARA TARA 811,627 $1.7m0.09% 0.09% AddedShares held: Q3 2023 209.2k, Q4 2023 209.2k, Q1 2024 209.2k, Q2 2024 811.6k +602.4k +602,400 287.9%
56 ATARA BIOTHERAPEUTICS INC COM COM 166,000 $1.4m0.07% 0.07% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 4.2m, Q2 2024 166.0k -4.0m -3,984,000 -96.0%
57 BIOATLA INC COM BCAB BCAB 686,347 $940.3k0.05% 0.05% UnchangedShares held: Q3 2023 686.3k, Q4 2023 686.3k, Q1 2024 686.3k, Q2 2024 686.3k
58 MILESTONE PHARMACEUTICALS IN COM MIST MIST 309,007 $407.9k0.02% 0.02% UnchangedShares held: Q3 2023 309.0k, Q4 2023 309.0k, Q1 2024 309.0k, Q2 2024 309.0k
59 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 250,000 $200.2k0.01% 0.01% ReducedShares held: Q3 2023 985.1k, Q4 2023 500.0k, Q1 2024 500.0k, Q2 2024 250.0k -250.0k -250,000 -50.0%
60 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 266,666 $42.7k0.00% 0.00% UnchangedShares held: Q3 2023 266.7k, Q4 2023 266.7k, Q1 2024 266.7k, Q2 2024 266.7k
61 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 66,666 $1.1k0.00% 0.00% UnchangedShares held: Q3 2023 66.7k, Q4 2023 66.7k, Q1 2024 66.7k, Q2 2024 66.7k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
VIKING THERAPEUTICS INC VKTX VKTX 300,000 $24.6m300.0k shares
DIREXION SHS ETF TR LABD LABD 350,000 $2.6m350.0k shares